drugset / Trial / NCT02195089

Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)

NCT02195089 ↗

Phase 1/2 Completed 19 enrolled BioLeaders Corporation
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy and the safety of BLS-ILB-E710c for the the fertile women with Cervical Intraepithelial Neoplasia (CIN3).

Timeline

Start
2014-03
Primary completion
2016-03
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject BLS-M07 Unknown 500 mg Oral
Subject BLS-M07 Unknown 1000 mg Oral
Subject BLS-M07 Unknown 1500 mg Oral